Profil
Daniel Harris Rosenbaum is currently the Chief Executive Officer at Kaydence Pharma USA. Prior to this, he was the Chief Executive Officer at NattoPharma ASA from 2015 to 2018.
He also worked as the General Manager-Nutraceuticals & Pharmaceutical at FMC Corp.
Mr. Rosenbaum completed his undergraduate degree at Cornell University and earned an MBA from Tuck School of Business at Dartmouth.
Aktiva positioner av Dan Rosenbaum
| Företag | Position | Start |
|---|---|---|
Kaydence Pharma USA
Kaydence Pharma USA Pharmaceuticals: MajorHealth Technology Develops menaquinone-7 for the treatment of vascular and tissue calcification-related diseases | Verkställande Direktör | - |
Tidigare kända positioner av Dan Rosenbaum
| Företag | Position | Slut |
|---|---|---|
| NATTOPHARMA ASA | Verkställande Direktör | 2018-02-10 |
| FMC CORPORATION | Företagsledare/Principal | - |
Dan Rosenbaums utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
FMC Corp.
FMC Corp. Chemicals: AgriculturalProcess Industries Operates as an agricultural sciences company which produces insecticides, herbicides and fungicides & crop nutrition and seed treatment products | Process Industries |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NattoPharma ASA
NattoPharma ASA Pharmaceuticals: MajorHealth Technology Manufactures, distributes, markets and sells vitamin K2 products | Health Technology |
Tuck School of Business at Dartmouth
Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kaydence Pharma USA
Kaydence Pharma USA Pharmaceuticals: MajorHealth Technology Develops menaquinone-7 for the treatment of vascular and tissue calcification-related diseases | Health Technology |
















